Gland Pharma share news, announcements and annual reports
NSE: GLANDBSE: 543245Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹3,049.00.
29 Oct: open ₹3,060.00, high ₹3,111.20, low ₹3,011.00
- Next results date: the board meets on 6 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹50,733 Cr261st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 44.94
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.90
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.65%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 11.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.02
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 3,86,09368.5% delivered
Gland Pharma has 548 announcements on record, routine notices left out; 6 in the 30 days to 29 Oct 2026, the latest on 23 Oct 2026.
Next board meeting and results date
As the company gave notice to the exchange.Gland Pharma quarterly results
The board meets on 6 Nov 2026 to consider financial results
Notice filed 21 Oct 2026
To consider and approve the financial results for the period ended September 30, 2026
Gland Pharma annual reports, presentations and earnings calls
The company's own documents, latest first.Gland Pharma financials, year by year
Annual reports6
- Annual report, year to Mar 202631 Jul 2026
- Annual report, year to Mar 202531 Jul 2025
- Annual report, year to Mar 20247 Aug 2024
- Annual report, year to Mar 20238 Aug 2023, a zip file
- Annual report, year to Mar 20225 Aug 2022, a zip file
1 earlier report
- Annual report, year to Mar 20212 Aug 2021, a zip file
Investor presentations24
- Investor Presentation10 Aug 2026
- Investor Presentation15 May 2026
- Investor Presentation28 Jan 2026
- Investor Presentation3 Nov 2025
- Investor Presentation5 Aug 2025
19 earlier presentations
- Investor Presentation20 May 2025
- Investor presentation3 Feb 2025
- Presentation4 Nov 2024
- Investor Presentation6 Aug 2024
- Investor Presentation22 May 2024
- Investor Presentation14 Feb 2024
- Investor Presentation6 Nov 2023
- Investor Presentation7 Aug 2023
- Investor Presentation18 May 2023
- Investor Presentation23 Jan 2023
- Presentation on the Proposed Acquisition of Cenexi Group29 Nov 2022
- Investor Presentation for Q2FY2326 Oct 2022
- Investor Presentation on the Q1FY23 Financial Results20 Jul 2022
- Investor Presentation on Q4FY22 Financial Results19 May 2022
- Investor Presentation21 Jan 2022
- Investor Presentation22 Oct 2021
- Investor Presentation7 Sep 2021
- Investor Presentation21 Jul 2021
- Investor Presentation17 May 2021
Earnings calls39
- Transcript17 Aug 2026
- Link of Recording10 Aug 2026
- Transcript20 May 2026
- Link of Recording15 May 2026
- Transcript3 Feb 2026
34 earlier call documents
- Link of Recording28 Jan 2026
- Transcript7 Nov 2025
- Link of Recording3 Nov 2025
- Transcript11 Aug 2025
- Link of Recording5 Aug 2025
- Transcript27 May 2025
- Link of Recording20 May 2025
- Transcript10 Feb 2025
- Link of Recording3 Feb 2025
- Transcript11 Nov 2024
- Link of Recording4 Nov 2024
- Transcript12 Aug 2024
- Link of Recording6 Aug 2024
- Transcript29 May 2024
- Link of Recording22 May 2024
- Transcript21 Feb 2024
- Link of Recording14 Feb 2024
- Transcript11 Nov 2023
- Link of Recording6 Nov 2023
- Link of Recording7 Aug 2023
- Transcript25 May 2023
- Link of Recording18 May 2023
- Earnings call Transcript for Q3FY2331 Jan 2023
- Link of Recording23 Jan 2023
- Recording of Analysts/Institutional Investor Meet/Con. Call29 Nov 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call2 Nov 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call26 Oct 2022
- Transcript of Earnings call for Q1FY2327 Jul 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call20 Jul 2022
- Transcript of Earnings call Transcript for Q4FY2226 May 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call19 May 2022
- Transcript28 Jan 2022
- Transcript of the Q2FY22 Earnings Call3 Nov 2021
- Earnings Call Transcript10 Feb 2021
Gland Pharma share news and announcements
Newest first. Page 1 of 11.
Oct 2026
21 Oct · Analysts
21 Oct · Board meeting
6 Oct · Meeting
1 Oct · Management
1 Oct · Board meeting
Sep 2026
13 Sep · Board meeting
13 Sep · General Updates
13 Sep · General Updates
10 Sep · Analysts
8 Sep · Analysts
4 Sep · Analysts
1 Sep
Aug 2026
31 Aug · Analysts
25 Aug · Meeting
23 Aug · Analysts
10 Aug · Analysts
10 Aug · Results
Jul 2026
31 Jul · Updates
31 Jul · Meeting
30 Jul · Updates
24 Jul · Analysts
24 Jul · Board meeting
20 Jul · Management
16 Jul · Legal
Jun 2026
22 Jun · Analysts
18 Jun · Meeting
17 Jun · Analysts
16 Jun · Analysts
16 Jun · Updates
15 Jun · Management
15 Jun · Board meeting
4 Jun · Analysts
May 2026
29 May · Analysts
26 May · Analysts
18 May · Analysts
15 May · Results
How the price met the news
The latest 30. The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 5 Oct 2026Board or managers changedup 1.29%+0.8 pts vs Nifty 500market median 0.0% · five sessions +6.5% (+6.5 pts vs Nifty 500) · volume 0.4× usual · delivery +17.0 pts against usual · The announcement
- 11 Aug 2026Resultsup 9.64%+9.9 pts vs Nifty 500market median −0.7% · five sessions +9.1% (+9.9 pts vs Nifty 500) · volume 19.6× usual · delivery −40.2 pts against usual · The announcement
- 16 Jun 2026Board or managers changeddown 1.55%−2.0 pts vs Nifty 500market median 0.0% · five sessions −1.2% (−2.8 pts vs Nifty 500) · volume 0.5× usual · delivery +9.9 pts against usual · The announcement
- 18 May 2026Resultsup 15.43%+15.7 pts vs Nifty 500market median −0.7% · five sessions +24.9% (+24.4 pts vs Nifty 500) · volume 48.0× usual · delivery −40.8 pts against usual · The announcement
- 4 Mar 2026Board or managers changeddown 4.81%−2.9 pts vs Nifty 500market median 0.0% · five sessions −5.9% (−3.8 pts vs Nifty 500) · volume 1.2× usual · delivery −6.1 pts against usual · The announcement
- 30 Jan 2026Board or managers changedup 2.58%+2.8 pts vs Nifty 500market median 0.0% · five sessions +5.0% (+3.2 pts vs Nifty 500) · volume 1.6× usual · delivery −22.4 pts against usual · The announcement
- 29 Jan 2026Resultsup 6.53%+6.3 pts vs Nifty 500market median −0.7% · five sessions +12.2% (+10.6 pts vs Nifty 500) · volume 22.2× usual · delivery −40.1 pts against usual · The announcement
- 4 Nov 2025Resultsdown 3.05%−2.5 pts vs Nifty 500market median −0.7% · five sessions −6.1% (−5.6 pts vs Nifty 500) · volume 3.8× usual · delivery −21.8 pts against usual · The announcement
- 29 Aug 2025Board or managers changeddown 0.81%−0.5 pts vs Nifty 500market median 0.0% · five sessions 0.0% (−1.3 pts vs Nifty 500) · volume 0.5× usual · delivery −9.2 pts against usual · The announcement
- 6 Aug 2025Resultsdown 0.37%+0.2 pts vs Nifty 500market median −0.7% · five sessions −1.6% (−0.6 pts vs Nifty 500) · volume 4.1× usual · delivery −14.4 pts against usual · The announcement
20 earlier announcements
- 21 May 2025Resultsup 4.87%+4.2 pts vs Nifty 500market median −0.7% · five sessions +2.0% (+1.0 pts vs Nifty 500) · volume 7.5× usual · delivery −30.5 pts against usual · The announcement
- 4 Feb 2025Resultsdown 3.66%−5.2 pts vs Nifty 500market median −0.7% · five sessions −2.4% (−2.2 pts vs Nifty 500) · volume 3.8× usual · delivery −2.0 pts against usual · The announcement
- 16 Jan 2025Board or managers changedup 0.08%−0.7 pts vs Nifty 500market median 0.0% · five sessions −2.4% (−1.7 pts vs Nifty 500) · volume 1.2× usual · delivery −19.1 pts against usual · The announcement
- 3 Dec 2024Board or managers changedup 1.82%+1.0 pts vs Nifty 500market median 0.0% · five sessions +0.7% (−1.3 pts vs Nifty 500) · volume 0.6× usual · delivery +0.7 pts against usual · The announcement
- 5 Nov 2024Resultsup 13.78%+13.1 pts vs Nifty 500market median −0.7% · five sessions +12.9% (+12.5 pts vs Nifty 500) · volume 32.7× usual · delivery −46.1 pts against usual · The announcement
- 21 Oct 2024Board or managers changedup 1.53%+2.3 pts vs Nifty 500market median 0.0% · five sessions −2.7% (+1.3 pts vs Nifty 500) · volume 1.0× usual · delivery −14.3 pts against usual · The announcement
- 11 Sep 2024Board or managers changeddown 2.04%−1.6 pts vs Nifty 500market median 0.0% · five sessions −4.2% (−5.6 pts vs Nifty 500) · volume 0.3× usual · delivery −7.7 pts against usual · The announcement
- 13 Aug 2024Board or managers changeddown 3.36%−2.4 pts vs Nifty 500market median 0.0% · five sessions −5.3% (−6.9 pts vs Nifty 500) · volume 0.6× usual · delivery −1.9 pts against usual · The announcement
- 7 Aug 2024Resultsdown 3.75%−5.6 pts vs Nifty 500market median −0.7% · five sessions −6.5% (−7.7 pts vs Nifty 500) · volume 5.1× usual · delivery −14.3 pts against usual · The announcement
- 10 Jun 2024Board or managers changedup 1.59%+1.4 pts vs Nifty 500market median 0.0% · five sessions −0.6% (−2.7 pts vs Nifty 500) · volume 0.3× usual · delivery −4.4 pts against usual · The announcement
- 3 Jun 2024Board or managers changedup 0.55%−2.7 pts vs Nifty 500market median 0.0% · five sessions +1.0% (−2.2 pts vs Nifty 500) · volume 1.1× usual · delivery +20.6 pts against usual · The announcement
- 23 May 2024Dividendup 4.95%+3.8 pts vs Nifty 500market median 0.0% · five sessions +3.8% (+3.7 pts vs Nifty 500) · volume 11.6× usual · delivery −34.8 pts against usual · The announcement
- 29 Apr 2024Board or managers changedup 0.05%−0.7 pts vs Nifty 500market median 0.0% · five sessions −1.4% (−1.6 pts vs Nifty 500) · volume 0.2× usual · delivery −4.0 pts against usual · The announcement
- 26 Mar 2024Board or managers changeddown 0.16%−0.2 pts vs Nifty 500market median 0.0% · five sessions −0.3% (−3.2 pts vs Nifty 500) · volume 0.3× usual · delivery −9.9 pts against usual · The announcement
- 15 Feb 2024Resultsdown 2.72%−3.3 pts vs Nifty 500market median −0.7% · five sessions +0.1% (−0.9 pts vs Nifty 500) · volume 5.5× usual · delivery +0.4 pts against usual · The announcement
- 7 Nov 2023Resultsup 4.97%+4.8 pts vs Nifty 500market median −0.7% · five sessions +3.9% (+2.8 pts vs Nifty 500) · volume 6.3× usual · delivery −4.3 pts against usual · The announcement
- 20 Sep 2023Board or managers changeddown 0.95%0.0 pts vs Nifty 500market median 0.0% · five sessions −3.9% (−2.0 pts vs Nifty 500) · volume 0.3× usual · delivery −3.3 pts against usual · The announcement
- 5 Sep 2023Board or managers changeddown 1.10%−1.5 pts vs Nifty 500market median 0.0% · five sessions −1.4% (−4.1 pts vs Nifty 500) · volume 0.5× usual · delivery −7.4 pts against usual · The announcement
- 8 Aug 2023Resultsup 20.00%+20.0 pts vs Nifty 500market median −0.7% · five sessions +19.4% (+20.2 pts vs Nifty 500) · volume 7.4× usual · delivery −15.7 pts against usual · The announcement
- 8 Aug 2023Board or managers changedup 20.00%+20.0 pts vs Nifty 500market median 0.0% · five sessions +19.4% (+20.2 pts vs Nifty 500) · volume 7.4× usual · delivery −15.7 pts against usual · The announcement
Gland Pharma results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.